Peer-reviewed research, conference presentations, and preprints from the Timeless Biosciences scientific team. Our therapeutic and platform strategy is grounded in rigorous evidence.
This work examines the clinical and scientific basis for individualized microbiome-targeted interventions, addressing the substantial inter-individual variability in microbiome composition and function that limits the efficacy of one-size-fits-all approaches. Jain provides a framework for precision microbiome modulation that informs the Timeless Biosciences therapeutic strategy.
Timeless Biosciences has additional scientific work in preparation, including a perspective piece on FMT donor screening standards and the emerging postbiotic paradigm, and mechanistic modeling manuscripts supporting the TB-001 scientific rationale. Updates will be posted here as submissions progress.